Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study

BACKGROUND: Patients with epidermal growth factor receptor (EGFR)‐mutated, advanced non–small cell lung cancer have received immunochemotherapy as one of the treatment options after tyrosine kinase inhibitor (TKI) failure. METHODS: We retrospectively examined EGFR‐mutant patients treated with atezol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Tae, Sakaguchi, Chikara, Hirano, Keita, Kobe, Hiroshi, Ishida, Masaki, Nakano, Takayuki, Tachibana, Yusuke, Tamiya, Nobuyo, Shiotsu, Shinsuke, Takeda, Takayuki, Yamada, Tadaaki, Yokoyama, Toshihide, Tsuchiya, Michiko, Nagasaka, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101833/
https://www.ncbi.nlm.nih.gov/pubmed/36866788
http://dx.doi.org/10.1111/1759-7714.14836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101833/
https://www.ncbi.nlm.nih.gov/pubmed/36866788
http://dx.doi.org/10.1111/1759-7714.14836

Ejemplares similares